Determinants of COVID-19-related lethality in multiple sclerosis: a meta-regression of observational studies.

Luca ProsperiniCarla TortorellaShalom HaggiagSerena RuggieriSimonetta GalganiClaudio Gasperini

Published in: Journal of neurology (2022)

Except for age and comorbidities, risk factors in common with the general population, we identified MS-specific determinants influencing the lethality of COVID-19. Our findings suggest the implementation of a risk mitigation plan for patients with progressive MS and for those treated with anti-CD20 agents.

Keyphrases

multiple sclerosis
coronavirus disease
sars cov
risk factors
white matter
mass spectrometry
primary care
healthcare
ms ms
respiratory syndrome coronavirus
nk cells